Keystone Symposia

This meeting took place in 2015

Here are the related meetings in 2021:
Next Generation HIV Vaccines & Therapies - RESCHEDULING IN PROGRESS (B4)

For a complete list of the meetings for the upcoming/current season, see our meeting list, or search for a meeting.

HIV Vaccines (X5)

Organizer(s) Giuseppe Pantaleo, Rafick P. Sekaly and Leonidas Stamatatos
March 22—27, 2015
Fairmont Banff Springs • Banff, AB Canada
Discounted Abstract Deadline: Nov 19, 2014
Abstract Deadline: Dec 17, 2014
Scholarship Deadline: Nov 19, 2014
Discounted Registration Deadline: Jan 20, 2015

Sponsored by Merck & Co., Inc. Part of the Keystone Symposia Global Health Series, supported by the Bill & Melinda Gates Foundation

Summary of Meeting:
As the 30th anniversary of the discovery of HIV has come and gone, HIV remains a catastrophic public health concern, with an estimated global prevalence of 34 million HIV-infected persons. Despite the remarkable advances in the development of several biomedical interventions for the prevention of HIV, the importance of developing an effective HIV vaccine has been recognized by a wide spectrum of the scientific community and civil society. Important milestones for the HIV vaccine field were the demonstration that a vaccine regimen could reduce HIV acquisition and the identification of binding IgG envelope (env) antibodies as potential correlates of protection from HIV acquisition. However, broad neutralizing antibodies (bNAbs) are thought to be the main mechanism of protection of the currently available effective vaccines. This meeting addresses the major scientific gaps in the generation of env bNAbs. Major areas covered by the meeting include: 1) Understanding the development of bNAbs in natural infections and following vaccination; 2) Determining predictors of response to vaccines; 3) Reviewing advances in envelope immunogen design; 4) The therapeutic use of bNAbs; 5) The application of novel technologies to monitor the immune response; and 6) The development of therapeutic strategies aimed to functional HIV cure. The meeting will bring together interdisciplinary groups with outstanding expertise in B- and T-cell biology, structural biology, vaccinology and clinical science. It will therefore provide insight into the attendees how innovative basic observations from the bench side may translate into the clinical development of vaccines and therapeutic interventions.

View Meeting Program


Keystone Symposia Future of Science Fund Scholarship Recipients

Rena D. Astronomo
Fred Hutchinson Cancer Research Center, USA

Jeong Hyun Lee
The Scripps Research Institute, USA

The Elkes Foundation Scholarship Recipients

Robert Abbott
La Jolla Institute for Allergy and Immunology, USA

Javier Guenaga
IAVI Neutralizing Antibody Center at TSRI, USA

Joseph G. Jardine
The Scripps Research Institute, USA

Keystone Symposia Global Health Travel Award Recipients, funded by the Bill & Melinda Gates Foundation

Anurag Adhikari
University of New South Wales, Australia

Annet Ajok
Medical Research Council/ UVRI Research Unit on AIDS, Uganda

Ebere Jennifer Anah
University of Port Harcourt, Nigeria

Barisisia Maxwell Barine
Emmadavistic Medical and Research Laboratories, Nigeria

Nithinart Chaitaveep
Armed Forces Research Institute of Medical Sciences, Thailand

Kolawole Asimiyu Fasakin
Federal Teaching Hospital, Nigeria

Shameem Z. Jaumdally
University of Cape Town, South Africa

Lubina Khan
All India Institute of Medical Sciences, India

Faatima Laher
Cape Town HVTN Immunology Laboratory, South Africa

Noemia Santana Lima
Fundação Oswaldo Cruz, Brazil

Chapdeleine Linda Mouafo Mekue
University of Dschang, Cameroon

Nompumelelo Prudence Mkhwanazi
University of KwaZulu-Natal, South Africa

Terence Mohammed
Botswana Harvard AIDS Institute Partnership, Botswana

Thandeka Moyo
University of Cape Town, South Africa

Daniel Muli Muema
Africa Health Research Institute, South Africa

Juliet Ndibazza
MRC/UVRI Uganda Research Unit on AIDS, Uganda

Nicholas Israel Nii-Trebi
Kumamoto University/ NIID, Japan, Japan

Bukola Olanike Oyebanji
Obafemi Awolowo University, Nigeria

David Lubulwa Senkaali
Uganda Virus Research Institute, Uganda

Berhanu Mekonnen Seyum
Addis Ababa University, Ethiopia